Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Issue 18 Executive Interviews
Understanding the new prescribing influences
Tom Haskell and John Moran of IMS’ Innovation Lab discuss how to evaluate new factors driving prescribing decisions.
No Comments
Rise of biologics
Nitin Sood of Agilent Automation Solutions explains the expansion of automation trends in life sciences.
No Comments
Understanding emerging markets
Eurand's Andrew Thompson shares insights on preparing for success in emerging markets.
No Comments
Optimizing your laboratory assets
GE Healthcare’s Matt Sawtell looks at the tools pharmaceutical companies can use to ensure they maximize their R&D dollars.
No Comments
Optimizing cell culture performance
Brandon Pence of Thermo Scientific Hyclone Products talks to NGP about achieving maximum output from process optimization collaborations.
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.